Enfusion

Enfusion Current Assets

Delisted

The Current Assets of Enfusion (ENFN) as of Nov 7, 2026 is 93.52 M USD. In the previous year, Current Assets was 69.85 M USD — a change of 33.88% (higher).

Current Assets

93.52 MUSD

YoY

33.88%

Last updated:

Current Assets of Enfusion is 2024 93.52 M USD. Current Assets of Enfusion was 2023 69.85 M USD. It decreases by 33.88% higher compared to the previous year.

The Enfusion Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2019
16.19 M USD
Jan 1, 2020
28.93 M USD
Jan 1, 2021
95.69 M USD
Jan 1, 2022
102.96 M USD
Jan 1, 2023
69.85 M USD
Jan 1, 2024
93.52 M USD
The Enfusion Current Assets history
YEARCurrent AssetsYoY
93.52 MUSD+33.88%
69.85 MUSD-32.15%
102.96 MUSD+7.60%
95.69 MUSD+230.74%
28.93 MUSD+78.70%
16.19 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Enfusion Stock analysis

What does Enfusion do? Enfusion Inc. generates revenue through cloud-native multi-tenant software solutions tailored for alternative and institutional investment managers. Its core products include the Portfolio Management System (PMS), Order and Execution Management System (OEMS), Accounting/General Ledger System, and Enfusion Analytics System, which collectively enable real-time investment decision-making. The company serves investment managers who require integrated systems for the full investment lifecycle, with PMS constructing and rebalancing portfolios while generating a real-time investment book of record, and OEMS facilitating electronic trade order communication for portfolio managers, traders, compliance teams, and analysts. The company's solution integrates technology-powered managed services to drive insights and control over investment operations. Enfusion's end-to-end functionality supports the entire investment process, from portfolio construction to trade execution, with PMS and OEMS operating in tandem to provide a seamless workflow. Investment managers across alternative and institutional segments purchase these integrated systems to enhance operational efficiency and decision-making capabilities. Enfusion's software is designed to serve the full investment lifecycle, with its systems integrated to provide a unified platform for portfolio management, order execution, accounting, and analytics. The company's revenue model is based on delivering these comprehensive solutions to investment managers who rely on real-time data and integrated workflows to manage their operations effectively. Enfusion is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Enfusion stock

Current Assets of Enfusion is 93.52 M USD in 2024.

Current Assets of Enfusion changed from 69.85 M USD to 93.52 M USD, representing a 33.88% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Enfusion since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Enfusion historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Enfusion

All Key Metrics — Enfusion